EUVIMEDEUVIMED entdecken
Open Access

SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway

Minghao Fan, Zhenmei Chen, Weiqing Shao, Yiran Chen, Zhifei Lin, Chenhe Yi, Yitong Li, Lu Lu, Yu Zhou, Jing Lin

Acta Biochimica et Biophysica Sinica · 2023

DOI: 10.3724/abbs.2023122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biochimica et Biophysica Sinica, 2023. Verfasst von Minghao Fan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsHumansAnimalsMiceCell ProliferationPhenylurea CompoundsTOR Serine-Threonine KinasesCell Line, TumorQuinolinesBetulinic Acid

Stichwörter der Autor:innen

SREBP2betulincholesterolhepatocellular carcinomainterleukin-1βlenvatinib

Substanzen

Phenylurea CompoundsTOR Serine-Threonine KinaseslenvatinibQuinolinesbetulinBetulinic Acid

Autor:innen und Institutionen

  • Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China.
  • Department of Infectious Diseases, the Third Afflicted Hospital of Wenzhou Medical University, Wenzhou 325200, China.

Zitieren

APA

Fan, M., Chen, Z., Shao, W., Chen, Y., Lin, Z., Yi, C., Li, Y., Lu, L., Zhou, Y., & Lin, J. (2023). SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2023122

Vancouver

Fan M, Chen Z, Shao W, Chen Y, Lin Z, Yi C, et al. SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway. Acta Biochimica et Biophysica Sinica. 2023. doi:10.3724/abbs.2023122

BibTeX
@article{Fan2023,
  author = {Fan, Minghao and Chen, Zhenmei and Shao, Weiqing and Chen, Yiran and Lin, Zhifei and Yi, Chenhe and Li, Yitong and Lu, Lu and Zhou, Yu and Lin, Jing},
  title = {SREBP2 inhibitor betulin sensitizes hepatocellular carcinoma to lenvatinib by inhibiting the mTOR/IL-1β pathway},
  journal = {Acta Biochimica et Biophysica Sinica},
  year = {2023},
  doi = {10.3724/abbs.2023122}
}
Kostenlos starten →